Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Alain, Mita"'
Autor:
Sapna Patel, Alain Mita, Kyriakos P Papadopoulos, Justine Cohen, Alexander Shoushtari, Jordi Rodon, Marlana Orloff, Marya Chaney, Carolyn Muller, Jessica Lin, Tina Garyantes, Monica Mita, Christopher Natale, Jeffrey Ishizuka
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/eea4b5f77786436a94e0b9b2b34ee5b4
Autor:
Angela Alistar, Alain Mita, Devalingam Mahalingam, Anthony El-Khoueiry, Jeongjun Kim, Hyunji Ahn, Jinho Choi, Seung-Hee Ryu, Jiye Ahn, Bae Jung Choi, Hwankyu Kang, Yeong-In Yang, Seung-Joo Lee, Borami Jeon, Stefan Proniuk, Kiyean Nam
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/7b62f76ff37b4f64b88e92009cae8e48
Autor:
Adil Daud, Ezra Cohen, Matthew Reilley, Siwen Hu-Lieskovan, Shubham Pant, Raphael Clynes, Roger Cohen, Anthony Shields, Mark Stein, Alain Mita, Bartosz Chmielowski, Yana Najjar, Elaine Shum, Joaquina Baranda, R Donald Harvey, Catherine Fleener, Ying Ding, Sowmya Chollate, Jolene Shorr, Barbara Hickingbottom, Lei Bao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/6a7db806111f4ca8b46be50a0a23239a
Autor:
Hendrik-Tobias Arkenau, Emiliano Calvo, Alain Mita, Young Kwang Chae, Devalingam Mahalingam, Ugur Sahin, Elena Garralda, Oezlem Tuereci, Vladimir Galvao, Stefan Symeonides, Maria Miguel, Hariz Hassan, Annette Baumhauer, Timo Völker, Marie-Cristine Kühnle, Roman Rösemann, Stefan Strobl
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/f934ebca1c46480bbd8a10a2221a40bb
Autor:
Nicolas Penel, Ulrich Keilholz, Ani Balmanoukian, Manish R Patel, Sanjay Goel, Keun-Wook Lee, Alain Mita, Christophe Le Tourneau, Deborah J Wong, Patrick Schöffski, Marcis Bajars, Amaury Daste, Hans Juergen Grote, Dongli Zhou, Michael S Gordon, Martin Gutierrez, Damien Vansteene, Joël Guigay
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/97c536fe1ca34848aead523f055e6235
Autor:
Hyun Cheol Chung, Hendrik-Tobias Arkenau, Jeeyun Lee, Sun Young Rha, Do-Youn Oh, Lucjan Wyrwicz, Yoon-Koo Kang, Keun-Wook Lee, Jeffrey R. Infante, Sung Sook Lee, Margaret Kemeny, Ulrich Keilholz, Bohuslav Melichar, Alain Mita, Ruth Plummer, Denis Smith, Arnold B. Gelb, Huiling Xiong, Janet Hong, Vikram Chand, Howard Safran
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Abstract Background We evaluated the antitumor activity and safety of avelumab, a human anti–PD-L1 IgG1 antibody, as first-line switch-maintenance (1 L-mn) or second-line (2 L) treatment in patients with advanced gastric/gastroesophageal cancer (GC
Externí odkaz:
https://doaj.org/article/22a26bd6feb14e4185d7a995dfe688b6
Autor:
Adil Daud, Rom Leidner, Ezra Cohen, Matthew Reilley, Siwen Hu-Lieskovan, Raphael Clynes, Roger Cohen, John Thompson, Mark Stein, Alain Mita, Bartosz Chmielowski, Yana Najjar, Elaine Shum, R Donald Harvey, Catherine Fleener, Ying Ding, Sowmya Chollate, Hector Avina, Jolene Shorr, Barbara Hickingbottom
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/7dc52d27a41d43ff9ad5408e51584f5b
Autor:
Hannah Lee, Vimal Krishnan, Lori J. Wirth, Carmelo Nucera, Mariza Venturina, Peter M. Sadow, Alain Mita, Wendy Sacks
Publikováno v:
Thyroid. 32:1580-1585
Autor:
Edward Wolin, Alain Mita, Amit Mahipal, Tim Meyer, Johanna Bendell, John Nemunaitis, Pam N Munster, Luis Paz-Ares, Ellen H Filvaroff, Shaoyi Li, Kristen Hege, Hans de Haan, Monica Mita
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0221994 (2019)
Second-generation mammalian target of rapamycin (mTOR) inhibitors such as CC-223 may have theoretical advantages over first-generation drugs by inhibiting TOR kinase in mTOR complex 1 (mTORC1) and 2 (mTORC2), potentially improving clinical efficacy f
Externí odkaz:
https://doaj.org/article/6826e5d056cc437e95d2b64f908d0efe
Autor:
Josep Tabernero, Jeffrey Infante, Hong Xie, Trilok Parekh, Italo Poggesi, Ademi Santiago-Walker, Bob Zhong, Martha Gonzalez, Alexander Spira, Ramaswamy Govindan, Victor Moreno, Emiliano Calvo, Mark Awad, Nancy Chan, Andres Cervantes, Alain Mita, Cinta Hierro, Antoine Italiano, Rastislav Bahleda
Supplementary Figure S1. Mean concentration-time erdafitinib profiles after a single dose (cycle 1 day 1 [C1D1]) and at steady-state (cycle 2 day 1 [C2D1]) after daily dosing (Panel A) or intermittent dosing (Panel B). 9 mg QD Part 1 at Cycle 2 Day 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00acc2d3f00797dbaef39a6ed0dbfe43
https://doi.org/10.1158/1078-0432.22473305
https://doi.org/10.1158/1078-0432.22473305